Covenant Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552K | Sell |
7,991
-3,094
| -28% | -$214K | 0.16% | 66 |
|
|
2025
Q1 | $770K | Sell |
11,085
-6,311
| -36% | -$438K | 0.25% | 48 |
|
|
2024
Q4 | $1.5M | Sell |
17,396
-130
| -0.7% | -$11.2K | 0.46% | 27 |
|
|
2024
Q3 | $2.09M | Buy |
17,526
+130
| +0.7% | +$15.5K | 0.61% | 20 |
|
|
2024
Q2 | $2.48M | Hold |
17,396
| – | – | 0.75% | 17 |
|
|
2024
Q1 | $2.23M | Hold |
17,396
| – | – | 0.65% | 17 |
|
|
2023
Q4 | $1.8M | Hold |
17,396
| – | – | 0.57% | 18 |
|
|
2023
Q3 | $1.58M | Sell |
17,396
-390
| -2% | -$35.5K | 0.57% | 17 |
|
|
2023
Q2 | $1.44M | Buy |
17,786
+390
| +2% | +$31.6K | 0.52% | 20 |
|
|
2023
Q1 | $1.38M | Buy |
17,396
+3,948
| +29% | +$314K | 0.53% | 22 |
|
|
2022
Q4 | $910K | Buy |
+13,448
| New | +$910K | 0.37% | 41 |
|